Medline's $6.26bn IPO marks turning point for medical supply sector capital flows
Article excerpt
Highlighted: the sentence this signal was extracted from
Medline's $6.26bn IPO marks turning point for medical supply sector capital flows. Medline raised $6.26B in 2025's biggest IPO, aiming to cut debt and expand operations. Find out what this means for investors, rivals, and the IPO market. Medline Industries priced its long-anticipated initial public offering at $29 per share, raising $6.26 billion in the largest IPO of 2025. The Illinois-based medical supplier sold approximately 216 million shares, and its stock is expected to begin trading on the Nasdaq under the ticker "MDLN." The offering marks a strategic inflection point for its private equity owners Blackstone, Carlyle, and Hellman & Friedman and reopens the window for large-scale healthcare IPOs.
